Samsung BioLogics

Europe Legal Chronicle. April 14, 2022

Samsung BioLogics’ USD2.3 Billion Acquisition of Samsung Bioepis

By Giulia Di Palma

Linklaters advised Samsung BioLogics on the deal. Samsung BioLogics, a Korean company active in the development and manufacturing of biopharmaceutical products worldwide, in its agreement with...

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here

BETA Technologies’ $300 Million Series C Equity Capital

Berkshire Partners’ $7.8 Billion Closing of Berkshire Fund XI

Francisco Partners’ Investment in Evite

Pampa Energía’s US$84 Million Notes Issuance

Vista’s US$150 Million Notes Issuance

Plascar’s R$55 Million Commercial Notes Issuance

ORLEN Group’s €2 Billion Credit Facility

Moog’s Sale of a Luxembourg Business to AXXERON Technologies

Challenge-trg Group’s Transition To An Employee Ownership Trust

Camusat Holding’s €81 Million Mezzanine Investment Round

Retail Holding’s Shareholders Reconfiguration

Ora Developers Egypt for Real Estate Investment’s Financing Round

Kokshetau Hospital’s €365 Million PPP Financing

Fourth Milling Company’s Initial Public Offering on Tadawul

A101 Yeni Magazacilik A.S.’ $200 Million Sustainability Loan

Waaree Energies’ $515 Million IPO

Bureau Veritas’ Acquisition Of The APP Group From Five V Capital

Pilbara’s Revolving Credit Facility

High-Profile Employment Litigator Joins Polsinelli in D.C.

O’Melveny Welcomes Experienced Houston Energy Lawyer David Aaronson

Paul Hastings Enhances Premier Private Equity and M&A Platform with New York Finance Partner

The Diarra Ruling On The Transfer Of Players Within The EU And The FIFA Regulation On The Status And Transfer Of Players

The Distinctive Character Of The ‘Vespa’ Is No Longer In Question

Cultural Heritage Sites With Restrictions On Intended Use: The Council of State Acknowledges That This Power Lies In the Hands Of The Ministry Of Culture

High-Profile Employment Litigator Joins Polsinelli in D.C.

O’Melveny Welcomes Experienced Houston Energy Lawyer David Aaronson

Paul Hastings Enhances Premier Private Equity and M&A Platform with New York Finance Partner

Samsung BioLogics’ USD2.3 Billion Acquisition of Samsung Bioepis

Standard 1 Year Membership Required